{"id":"https://openalex.org/W2018262914","doi":"https://doi.org/10.1097/inf.0000000000000465","title":"Dissecting the Immune Response to MF59-adjuvanted and Nonadjuvanted Seasonal Influenza Vaccines in Children Less Than Three Years of Age","display_name":"Dissecting the Immune Response to MF59-adjuvanted and Nonadjuvanted Seasonal Influenza Vaccines in Children Less Than Three Years of Age","publication_year":2014,"publication_date":"2014-07-17","ids":{"openalex":"https://openalex.org/W2018262914","doi":"https://doi.org/10.1097/inf.0000000000000465","mag":"2018262914","pmid":"https://pubmed.ncbi.nlm.nih.gov/25037034"},"language":"en","primary_location":{"id":"doi:10.1097/inf.0000000000000465","doi":"https://doi.org/10.1097/inf.0000000000000465","is_oa":false,"landing_page_url":"https://doi.org/10.1097/inf.0000000000000465","pdf_url":null,"source":{"id":"https://openalex.org/S109369870","display_name":"The Pediatric Infectious Disease Journal","issn_l":"0891-3668","issn":["0891-3668","1532-0987"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Infectious Disease Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048274724","display_name":"Luisanna Zedda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I132053463","display_name":"Universit\u00e9 Libre de Bruxelles","ror":"https://ror.org/01r9htc13","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Luisanna Zedda","raw_affiliation_strings":["From the *Novartis Vaccines, Siena, Italy and Cambridge, MA; \u2020Sint Vincentius Ziekenhuis, Antwerp, Belgium; \u2021Kinderartsenassociatie, Hasselt, Belgium; \u00a7ImmuneHealth, Charleroi, Belgium; and \u00b6Institute for Medical Immunology, Universit\u00e9 Libre de Bruxelles, Charleroi, Belgium","Novartis Vaccines, Siena, Italy and Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the *Novartis Vaccines, Siena, Italy and Cambridge, MA; \u2020Sint Vincentius Ziekenhuis, Antwerp, Belgium; \u2021Kinderartsenassociatie, Hasselt, Belgium; \u00a7ImmuneHealth, Charleroi, Belgium; and \u00b6Institute for Medical Immunology, Universit\u00e9 Libre de Bruxelles, Charleroi, Belgium","institution_ids":["https://openalex.org/I132053463"]},{"raw_affiliation_string":"Novartis Vaccines, Siena, Italy and Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074062985","display_name":"Eduardo Forleo\u2010Neto","orcid":"https://orcid.org/0000-0003-1959-8156","observed_orcids":["https://orcid.org/0000-0003-1959-8156"]},"institutions":[{"id":"https://openalex.org/I4210139938","display_name":"Novartis (Italy)","ror":"https://ror.org/04rcxhq50","country_code":"IT","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210139938"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Eduardo Forleo-Neto","raw_affiliation_strings":["Novartis Vaccines, Siena, Italy and Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Vaccines, Siena, Italy and Cambridge, MA","institution_ids":["https://openalex.org/I4210139938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010212853","display_name":"Andr\u00e9 Vertruyen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andr\u00e9 Vertruyen","raw_affiliation_strings":["Sint Vincentius Ziekenhuis, Antwerp, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sint Vincentius Ziekenhuis, Antwerp, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109914542","display_name":"Marc Raes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marc Raes","raw_affiliation_strings":["Kinderartsenassociatie, Hasselt, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kinderartsenassociatie, Hasselt, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011424051","display_name":"Arnaud Marchant","orcid":"https://orcid.org/0000-0003-0578-0467","observed_orcids":["https://orcid.org/0000-0003-0578-0467"]},"institutions":[{"id":"https://openalex.org/I132053463","display_name":"Universit\u00e9 Libre de Bruxelles","ror":"https://ror.org/01r9htc13","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Arnaud Marchant","raw_affiliation_strings":["ImmuneHealth, Charleroi, Belgium","ImmuneHealth, Charleroi, Belgium; and","Institute for Medical Immunology, Universit\u00e9 Libre de Bruxelles, Charleroi, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmuneHealth, Charleroi, Belgium","institution_ids":[]},{"raw_affiliation_string":"ImmuneHealth, Charleroi, Belgium; and","institution_ids":[]},{"raw_affiliation_string":"Institute for Medical Immunology, Universit\u00e9 Libre de Bruxelles, Charleroi, Belgium","institution_ids":["https://openalex.org/I132053463"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Wim Jansen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139938","display_name":"Novartis (Italy)","ror":"https://ror.org/04rcxhq50","country_code":"IT","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210139938"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Wim Jansen","raw_affiliation_strings":["Novartis Vaccines, Siena, Italy and Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Vaccines, Siena, Italy and Cambridge, MA","institution_ids":["https://openalex.org/I4210139938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045015412","display_name":"Heather Clouting","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139938","display_name":"Novartis (Italy)","ror":"https://ror.org/04rcxhq50","country_code":"IT","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210139938"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Heather Clouting","raw_affiliation_strings":["Novartis Vaccines, Siena, Italy and Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Vaccines, Siena, Italy and Cambridge, MA","institution_ids":["https://openalex.org/I4210139938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075008573","display_name":"Ashwani Kumar Arora","orcid":"https://orcid.org/0000-0003-3694-9878","observed_orcids":["https://orcid.org/0000-0003-3694-9878"]},"institutions":[{"id":"https://openalex.org/I4210139938","display_name":"Novartis (Italy)","ror":"https://ror.org/04rcxhq50","country_code":"IT","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210139938"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Ashwani Arora","raw_affiliation_strings":["Novartis Vaccines, Siena, Italy and Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Vaccines, Siena, Italy and Cambridge, MA","institution_ids":["https://openalex.org/I4210139938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025652033","display_name":"Mark Edward Beatty","orcid":"https://orcid.org/0000-0002-9614-5938","observed_orcids":["https://orcid.org/0000-0002-9614-5938"]},"institutions":[{"id":"https://openalex.org/I4210139938","display_name":"Novartis (Italy)","ror":"https://ror.org/04rcxhq50","country_code":"IT","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210139938"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Mark E. Beatty","raw_affiliation_strings":["Novartis Vaccines, Siena, Italy and Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Vaccines, Siena, Italy and Cambridge, MA","institution_ids":["https://openalex.org/I4210139938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103578650","display_name":"Grazia Galli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139938","display_name":"Novartis (Italy)","ror":"https://ror.org/04rcxhq50","country_code":"IT","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210139938"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Grazia Galli","raw_affiliation_strings":["Novartis Vaccines, Siena, Italy and Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Vaccines, Siena, Italy and Cambridge, MA","institution_ids":["https://openalex.org/I4210139938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005716316","display_name":"Giuseppe Del Giudice","orcid":"https://orcid.org/0000-0002-4585-4590","observed_orcids":["https://orcid.org/0000-0002-4585-4590"]},"institutions":[{"id":"https://openalex.org/I4210139938","display_name":"Novartis (Italy)","ror":"https://ror.org/04rcxhq50","country_code":"IT","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210139938"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Giuseppe Del Giudice","raw_affiliation_strings":["Novartis Vaccines, Siena, Italy and Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Vaccines, Siena, Italy and Cambridge, MA","institution_ids":["https://openalex.org/I4210139938"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013178279","display_name":"Flora Castellino","orcid":"https://orcid.org/0000-0002-3432-9846","observed_orcids":["https://orcid.org/0000-0002-3432-9846"]},"institutions":[{"id":"https://openalex.org/I4210139938","display_name":"Novartis (Italy)","ror":"https://ror.org/04rcxhq50","country_code":"IT","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210139938"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Flora Castellino","raw_affiliation_strings":["Novartis Vaccines, Siena, Italy and Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Vaccines, Siena, Italy and Cambridge, MA","institution_ids":["https://openalex.org/I4210139938"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5005716316","https://openalex.org/A5013178279","https://openalex.org/A5025652033","https://openalex.org/A5045015412","https://openalex.org/A5048274724","https://openalex.org/A5074062985","https://openalex.org/A5075008573","https://openalex.org/A5103578650"],"corresponding_institution_ids":["https://openalex.org/I132053463","https://openalex.org/I4210139938"],"apc_list":null,"apc_paid":null,"fwci":2.5168,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.88324914,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"34","issue":"1","first_page":"73","last_page":"78"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mf59-adjuvant","display_name":"MF59 adjuvant","score":0.8820000290870667},{"id":"https://openalex.org/keywords/seasonal-influenza-vaccine","display_name":"seasonal influenza vaccine","score":0.7829999923706055},{"id":"https://openalex.org/keywords/trivalent-inactivated-influenza-vaccine","display_name":"trivalent inactivated influenza vaccine","score":0.9049999713897705},{"id":"https://openalex.org/keywords/children-under-3-years","display_name":"children under 3 years","score":0.6859999895095825},{"id":"https://openalex.org/keywords/vaccine-immunogenicity","display_name":"vaccine immunogenicity","score":0.8109999895095825},{"id":"https://openalex.org/keywords/hemagglutination-inhibition-antibodies","display_name":"hemagglutination inhibition antibodies","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cd4-t-cell-responses","display_name":"CD4+ T cell responses","score":0.7820000052452087},{"id":"https://openalex.org/keywords/cytokine-profile","display_name":"cytokine profile","score":0.7910000085830688},{"id":"https://openalex.org/keywords/th1-th2-balance","display_name":"Th1/Th2 balance","score":0.9369999766349792},{"id":"https://openalex.org/keywords/oil-in-water-adjuvant","display_name":"oil-in-water adjuvant","score":0.7310000061988831},{"id":"https://openalex.org/keywords/vaccine-tolerance","display_name":"vaccine tolerance","score":0.42100000381469727}],"concepts":[{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.8717082738876343},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.8366168737411499},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7016912698745728},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6281479597091675},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5788388252258301},{"id":"https://openalex.org/C2780689484","wikidata":"https://www.wikidata.org/wiki/Q383260","display_name":"Influenza vaccine","level":3,"score":0.5116479992866516},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.49182724952697754},{"id":"https://openalex.org/C182072434","wikidata":"https://www.wikidata.org/wiki/Q3985103","display_name":"Hemagglutination assay","level":4,"score":0.48168596625328064},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4715057909488678},{"id":"https://openalex.org/C3018913218","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody response","level":3,"score":0.44931358098983765},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.44052284955978394},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.43152475357055664}],"mesh":[{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006385","descriptor_name":"Hemagglutination Inhibition Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007252","descriptor_name":"Influenza Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007252","descriptor_name":"Influenza Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011136","descriptor_name":"Polysorbates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013185","descriptor_name":"Squalene","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/inf.0000000000000465","doi":"https://doi.org/10.1097/inf.0000000000000465","is_oa":false,"landing_page_url":"https://doi.org/10.1097/inf.0000000000000465","pdf_url":null,"source":{"id":"https://openalex.org/S109369870","display_name":"The Pediatric Infectious Disease Journal","issn_l":"0891-3668","issn":["0891-3668","1532-0987"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Infectious Disease Journal","raw_type":"journal-article"},{"id":"pmid:25037034","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25037034","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Pediatric infectious disease journal","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:dipot.ulb.ac.be:2013/196316","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/196316","pdf_url":null,"source":{"id":"https://openalex.org/S4306401063","display_name":"D\u00e9p\u00f4t institutionnel de l'Universit\u00e9 libre de Bruxelles (Universit\u00e9 Libre de Bruxelles)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I132053463","host_organization_name":"Universit\u00e9 Libre de Bruxelles","host_organization_lineage":["https://openalex.org/I132053463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Pediatric infectious disease journal, 34 (1","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1603538170","https://openalex.org/W1963590894","https://openalex.org/W1965145857","https://openalex.org/W1982855609","https://openalex.org/W1984346378","https://openalex.org/W2028587022","https://openalex.org/W2048092342","https://openalex.org/W2060979783","https://openalex.org/W2073228170","https://openalex.org/W2074282824","https://openalex.org/W2075196857","https://openalex.org/W2075877458","https://openalex.org/W2103758376","https://openalex.org/W2109801797","https://openalex.org/W2132026089","https://openalex.org/W2156580403","https://openalex.org/W2159943749"],"related_works":["https://openalex.org/W2075877458","https://openalex.org/W2043687544","https://openalex.org/W2771874921","https://openalex.org/W2028587022","https://openalex.org/W1587032376","https://openalex.org/W2075196857","https://openalex.org/W2755826838","https://openalex.org/W2795611591","https://openalex.org/W2236650526","https://openalex.org/W2047393181"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Annual":[1],"seasonal":[2],"influenza":[3,30,65,213],"epidemics":[4],"are":[5],"particularly":[6],"dangerous":[7],"for":[8,174,190],"the":[9,12,57,107,111,119,132,138,142,148,158,175,183,191,198,203,209],"very":[10],"young,":[11],"elderly":[13],"and":[14,26,36,59,93,152,154,189],"chronically":[15],"ill":[16],"individuals,":[17],"in":[18,38,76,110,182,207,215],"whom":[19],"infection":[20],"can":[21],"cause":[22],"severe":[23],"morbidity,":[24],"hospitalization":[25],"death.":[27],"Existing,":[28],"nonadjuvanted":[29],"vaccines":[31,214],"exhibit":[32],"a":[33,63,123],"suboptimal":[34],"immunogenicity":[35,210],"efficacy":[37],"immunologically":[39,216],"naive":[40,217],"subjects":[41],"such":[42],"as":[43],"young":[44],"children.":[45],"METHODS:":[46],"This":[47],"phase":[48],"II,":[49],"randomized":[50],"clinical":[51],"trial":[52],"was":[53,90,171],"conducted":[54],"to":[55,62,102],"evaluate":[56],"antibody":[58],"cell-mediated":[60],"responses":[61],"trivalent":[64],"vaccine":[66,89,112],"administered":[67],"without":[68],"adjuvant":[69,120,133,205],"(TIV)":[70],"or":[71,163],"adjuvanted":[72],"with":[73],"MF59":[74,121,134,206],"(ATIV)":[75],"previously":[77],"nonvaccinated":[78],"children":[79],"less":[80],"than":[81,114],"3":[82],"years":[83,184],"of":[84,97,118,126,141,150,167,211],"age.":[85],"RESULTS:":[86],"The":[87,116,165],"MF59-adjuvanted":[88],"well":[91],"tolerated,":[92],"induced":[94,122],"higher":[95],"titers":[96],"hemagglutination":[98],"inhibition":[99],"antibodies":[100],"able":[101],"recognize":[103],"strains":[104,177],"different":[105],"from":[106],"one":[108],"used":[109],"(heterovariant)":[113],"TIV.":[115],"presence":[117],"larger":[124],"expansion":[125],"vaccine-specific":[127],"CD4":[128],"T":[129,144],"cells.":[130],"Interestingly,":[131],"did":[135,155],"not":[136,156,180],"modify":[137],"cytokine":[139],"profile":[140],"elicited":[143],"cells,":[145],"characterized":[146],"by":[147,202],"production":[149],"IL-2":[151],"TNF-\u03b1,":[153],"bias":[157],"response":[159],"toward":[160],"either":[161],"Th1":[162],"Th2.":[164],"advantage":[166],"ATIV":[168],"over":[169],"TIV":[170],"more":[172],"pronounced":[173],"virus":[176],"that":[178,185],"had":[179],"circulated":[181],"preceded":[186],"this":[187],"study":[188],"heterovariant":[192],"strains.":[193],"CONCLUSION:":[194],"These":[195],"data":[196],"highlight":[197],"relevant":[199],"role":[200],"played":[201],"oil-in-water":[204],"enhancing":[208],"inactivated":[212],"individuals.":[218]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}